25
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Anaplastic Large Cell Lymphoma: Update of Findings

, , , , , , & show all
Pages 17-25 | Received 05 Aug 1994, Published online: 01 Jul 2009

References

  • Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter G., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cell. Blood 1985; 66: 848
  • Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., Diehl V. Production of a monoclonal antibody specific for Hodgkin and Stemberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65
  • Fonatsch C., Latza U., Durkop H., Reider H., Stein H. Assignment of the human CD30 (Ki-1) gene to lp36. Genomics 1992; 14: 825
  • Durkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. Molecular cloning and expression of a new member of the Nerve Growth Factor Receptor family which is characteristic for Hodgkin's disease. Cell 1992; 68: 1
  • Smith C.A., Gruss H.J., Davis T., Anderson D., Farrah T., Baker E., Sutherland G. R., Brannan C. I., Copeland N. G., Jenkins N. A., Grabstein K. H., Gliniak B., McAlister I. B., Fanslow W., Alderson M., Falk B., Gimpel S., Gillis S., Din W. S., Goodwin R. G., Armitage R. J. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349
  • Kadin M. E., Sako D., Berliner N., Franklin W., Woda B., Borowitz M., Ireland K., Schweid A., Herzog P., Lange B., Doreman R. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 68: 1042
  • Schnitzer B., Roth M. S., Hyder D. M., Ginsburg D. Ki-1 lymphomas in children. Cancer 1988; 61: 1213
  • Agnarsson B. A., Kadin M. E. Ki-1 positive large cell lymphoma. Am. J. Surg. Pathol 1988; 12: 264
  • Stansfeld A. G., Diebold J., Kapanci Y., Kelenyi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., van Unnik J. A. M., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292
  • Schwarting R., Gerdes J., Durkop H., Falini B., Pileri S., Stein H. Ber-H2: a new anti Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989; 74: 1678
  • Pallesen G. The diagnostic significance of the CD30 (Ki-1) antigen. Histopathol 1990; 16: 409
  • Chang K. L., Arber D. A., Weiss L. M. CD30: a review. Applied Immunohistochem 1993; 1: 244
  • Piris M., Brown D. C., Gatter K. C., Mason D. Y. CD30 expression in non-Hodgkin's lymphoma. Histopathol 1990; 17: 211
  • Piris M., Gatter K., Mason D. CD30 expression in follicular lymphoma. Histopathol 1991; 18: 25
  • Moller P., Matthaei-Maurer U., Moldenhauer G. CD30 (Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma. Am. J. Clin. Pathol 1989; 91: 18
  • Pileri S., Falini B., Sabattini E., Bigerna B., Gherlinzoni F., Tazzari P. L. Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. Haematologica 1991; 76: 226
  • Lennert K., Feller A. C. Histopathology of non-Hodgkin's Lymphomas (based on the updated Kiel classification). Springer-Verlag, Berlin 1992
  • Chan J. K. C., Hui P. K., Leungs T. W., Lau W. H., McGuire L. J. Anaplastic large cell Ki-1 lymphoma: delineation of 2 morphological types. Histopathol 1989; 15: 11
  • Chott A., Kaserer K., Augustin I., Vasely M., Heinz R., Oehlinger W., Hanak H., Radaszkiewicz T. Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am. J. Surg. Pathol 1990; 14: 439
  • Falini B., Pileri S., Martelli M. F. Histological and immunohistological analysis of human lymphomas. CRC Crit. Rev. Oncol. Hematol 1989; 9: 351
  • Pileri S., Falini B., Delsol G., Stein H., Baglioni P., Poggi S., Rivano M. T., Mason D. Y., Martelli M. F., Stansfeld A. G. Lymphohistiocytic T cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathol 1990; 16: 383
  • Pileri S., Bocchia M., Baroni C. D., Martelli M., Falini B., Sabattini E., Gherlinzoni F., Amadori S., Poggi S., Mazza P., Burgio V., Zinzani P. L., Melilli G., Benni M., Saragoni L., Martelli M. F., Stein H., Mandelli F., Tura S. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases. Br. J. Haematol 1994; 86: 513
  • Radaszkiewicz T., Simonitsch I., Mosberger I., Chott A. Anaplastic large cell lymphoma: morphology and clinico-pathologic correlations. Proceedings of the Fifth International Conference on Malignant Lymphomas. Lugano, 1993, 1993
  • Stein H., Herbst H., Anagnostopoulos I., Niedobitek G., Dallenbach F., Kraozsch H.-C. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann. Oncol 1991; 2: 33
  • Harris N., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Müller-Hermelink H.-K., Pileri S., Piris M. A., Ralfkiaer E., Warnke R. A. A Revised European-American Classification of Lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, in press
  • Pileri S., Sabattini E., Poggi S., Amini M., Falini B., Stein H. Anaplastic large cell lymphoma, lympho-histiocytic type. Histopathol 1994; 25: 191
  • Jaffe E. S. Malignant histiocytosis and true histiocytic Lymphomas. Surgical Pathology of the Lymph Nodes and related Organs, E. S. Jaffe. Philadelphia., Saunders 1985; 381
  • Pileri S., Mazza P., Zinzani P. L., Poggi S., Poletti G., Falini B., Tura S. Ki-1 lymphoma and Hodgkin's disease. Haematologica 1989; 74: 333
  • Leoncini L., Del Vecchio M. T., Kraft R., Megha T., Barbini P., Cevenini G., Poggi S., Pileri S., Tosi P., Co Co Co Cottier H. Hodgkin's disease and CD30 positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders. Am. J. Pathol 1990; 137: 1047
  • Frizzera G. The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Seminars in Diagnostic Pathology 1992; 9(No. 4)291
  • MacLennan K. A., Bennett M. H., Vaughan Hudson B., Easterling J., Vaughan Hudson G., Jeliffe A. M. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. Cancer 1989; 64: 1686
  • Strickler J. G., Michie S. A., Warnke R. A., Dorfman R. F. The “syncytial” variant of nodular sclerosing Hodgkin's disease. Am. J. Surg. Pathol 1986; 10: 470
  • Chan J. K. C, Buchanam R., Fletcher C. D. M. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am. J. Surg. Pathol 1990; 14: 983
  • Kinney M. C., Glick A. D., Stein H., Collins R. D. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am. J. Surg. Pathol 1990; 14: 1047
  • Kinney M., Collins R., Whitlock J., Sioutos N., Kadin M. A small-cell predominant variant of primary Ki-1 (CD30)+ lymphoma. Am. J. Surg. Pathol 1993; 17: 859
  • Cattoretti G., Pileri S., Parravicini C., Becker M. H. G., Poggi S. S., Bifulco C., Key G., D'Amato L., Sabattini E., Feudale E., Reynolds F., Gerdes J., Rilke F. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol 1993; 171: 83
  • Falini B., Pileri S., Stein H., Dieneman D., Dallenbach F., Delsol G., Minelli O., Poggi S., Martelli M. F., Pallesen G., Palestro G. Variable expression of leucocyte-common antigen (CD45) in CD30 (Ki-1) positive anaplastic large cell lymphomas. Implications for the differential diagnosis between lymphoid and non-lymphoid malignancies. Hum. Pathol 1990; 21: 624
  • Falini B., Flenghi L., Pileri S., Gambacorta M., Bigerna B., Durkop H., Eitelbach F., Thiele J., Pacini R., Cavaliere A., Martelli M., Cardarelli N., Sabattini E., Poggi S., Stein H. PG-MI: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am. J. Pathol 1993; 142: 1359
  • Gustmann C., Altmannsberger M., Osborn M., Criesser H., Feller A. C. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am. J. Pathol 1991; 138: 1413
  • Delsol G., Al Saati T., Gatter K., Gerdes J., Schwarting R., Caveriviere P., Rigal-Huguet F., Robert A., Stein H., Mason D. Y. Co-expression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am. J. Pathol 1988; 130: 59
  • Rosso R., Paulli M., Magrini U., Kindl S., Boveri E., Volpato G., Poggi S., Baglioni P., Pileri S. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch 1989; 416: 1029
  • Perkins P. L., Ross C. W., Schnitzer B. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall. Arch. Pathol. Lab. Med 1992; 116: 1192
  • Delsol G., Blancher A., Al Saati T., Ralfkiaer E., Lauritzen A., Bruigères L. Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas. Br. J. Cancer 1991; 64: 321
  • Al Saati T., Meggetto F., Selves J., Brousset P., Delsol G. A new MoAb (CBF.78) reactive with high grade T-cell lymphomas in paraffin-embedded tissue sections. Tissue Antigens 1993; 42(No. 4)240
  • Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin's and Reed-Sternberg cells. PNAS 1991; 88: 4766
  • Duossis I. A., Pezzella F., Lane P. L., Gatter K. C., Mason D. Y. An immunocytochemical study of p53 and bel-2 protein expression in Hodgkin's disease. Am. J. Clin. Pathol 1993; 99: 663
  • O'Connor N. T. J., Stein H., Gatter K. C., Wainscoat J. S., Crick J., Al Saati T., Falini B., Delsol G., Mason D. Y. Genotypic analysis of Ki-1 positive large cell lymphomas. Histopathol 1987; 11: 733
  • Herbst H., Tippelmann G., Anagnostopoulos I., Gerdes J., Schwarting R., Boehm Th., Pileri S., Jones D. B., Stein H. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leukemia Res 1989; 13: 103
  • Stein H. Ki-1 anaplastic large cell lymphoma: is it a discrete entity?. Leukemia & Lymphoma 1993; 10: 81
  • Mason D. Y., Bastard C., Rimokh R., Dastugne N., Huret J.-L., Kristoffersson V., Magaud J.-P., Nezelof C., Tilly H., Vannier J.-P., Hemet J., Warnke R. A. CD30-positive large cell lymphomas (“ki-1 lymphoma”) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol 1990; 74: 161
  • Herbst H., Niedobitek G., Kneba M., Hummel M., Finn T., Anagnostopoulos I., Bergholz M., Krieger G., Stein H. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol 1990; 137: 13
  • Stein H., Hummel M. What is the origin of the malignant cell in Hodgkin's disease?. Leukemia & Lymphoma 1993; 10: 99
  • Herbst H., Stein H., Niedobitek G. Epstein-Barr virus and CD30+ malignant lymphomas. Crit. Rev. in Oncogen 1993; 4: 191
  • Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320
  • Delsol G., Brousset P., Chittal S., Rigal-Huguet F. Correlation of the expression of Epstein-Barr Virus Latent Membrane Protein and in situ hybridization with biotinylated BamHl-W probes in Hodgkin's disease. Am. J. Pathol 1992; 2: 247
  • Greer J. P., Kinney M. C., Collins R. D., Salhani K. E., Wolff S. N., Hainsworth J. D., Flexner J. M., Stein R. S. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J. Clin.Oncol 1991; 9: 539
  • Kadin M. E. Primary CD30+ anaplastic large cell lymphoma—A distinct clinicopathologic entity. Ann. Oncol 1994; 5: S25
  • Cabanillas F., Romaguerra J., Manning J. Ki-1 positive large cell lymphoma: is it a clinical entity?. Proceedings of the Fifth International Conference on Malignant Lymphomas. Lugano, 1993, 1993
  • Murphy S. B. Pediatric lymphomas: recent advances and commentary on Ki-1 positive anaplastic large cell lymphomas of childhood. Ann. Oncol 1994; 5: S31
  • Kadin M. E. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease. Sem. Dermatol 1991; 10: 164
  • Kaudewitz P., Stein H., Dallenbach F., Eckert F., Bieber K., Burg G., Braun-Falco O. Primary and secondary cutaneous Ki-1 + (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic and clinical characteristics. Am. J. Pathol 1989; 135: 359
  • Kadin M. E. The spectrum of Ki-1+ cutaneous lymphomas. Curr. Prob. Dermatol 1990; 19: 132
  • Kadin M. E., Cavaille-Coll M. W., Morton C. C. Tumor progression in Ki-1 + cutaneous T-cell lymphomas is related to escape from inhibition by transforming Growth Factor-B. Blood 1990; 76: 356
  • Bruin P., Beljaards R., van Heerde P., van Krieken J., Kluin-Nelemans J., Willemze R., Meijer C. Differences in clinical behaviour and immunophenothype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathol 1993; 23: 127
  • Beljaards R. C., Kaudewitz P., Berti E., Gianotti R., Neumann C., Rosso R., Paulli M., Meijer C. J. L. M., Willemze R. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients. Cancer 1993; 71: 2097
  • Motley R. J., Jasani B., Ford A. M., Poynton C. H., Calonje-Daly J. E., Holt P. J. A. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma. Cancer 1992; 70: 476
  • Weiss L. M., Wood G. S., Trela M., Warnke R. A., Sklar J. Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N. Engl. J. Med 1986; 315: 475
  • Massimino M., Gasparini M., Rottoli L., Luksch R., Lombardi F., Giardini R., Rilke F. Primary anaplastic large cell lymphoma (ALC-NHL) in children. Proceedings of the Fifth International Conference on Malignant Lymphoma. Lugano, 1993, 1993
  • Wong K. F., Chan J. K. C., Ng C. S., Chu Y. C., Lam P. W. Y., Yuen H. L. Anaplastic large cell Ki-1 lymphoma involving bone marrow: marrow findings and association with reactive hemophagocytosis. Am. J. Hematol 1991; 37: 112
  • Vecchi V., Burnelli R., Pileri S., Rosito P., Sabattini E., Civino A., Pericoli R., Paolucci G. Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood. Med. Ped. Oncol 1993; 21: 402
  • Reiter A., Schrappe M., Parwaresch M. R., Wacker M., Dopfer R., Schwabe D., Dorfel W., Gadner H., Riehm H. Large cell anaplastic lymphoma (LCAL) of childhood: a report of 45 patients uniformely treated according to the BFM B-NHL strategy. Proceedings of the Fifth International Conference on Malignant Lymphoma. Lugano, 1993, 1993 for the BFM Group
  • Offit K., Ladanyi M., Gangi M. D., Ebrahim S. A. D., Filippa D., Chagouti R. S. K. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 1990; 4: 625
  • D'Agay M. F., Briere J., Lepage E., Herbrecht R., Morel P., Tilly H., Symann M., Reyes F., Gaulard P., Delsol G., Diebold J., Coiffier B. Anaplastic large cell lymphoma in adults: a study of 140 cases with comparison to a cohort of 1225 non anaplastic large cell lymphoma included in the same LNH87 protocol. Proceedings of the Fifth International Conference on Malignant Lymphoma. Lugano, 1993, 1993
  • Pinkerton C. R., Gerrard M. Large cell anaplastic lymphoma in children. Outcome using high grade B cell chemotherapy. Proceedings of the Fifth International Conference on Malignant Lymphoma. Lugano, 1993; 1993
  • Chadburn A., Cesarman E., Jagirdur J., Subar M., Mir R. N., Knowles D. M. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993; 72: 3078

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.